Immunosuppression and the role of suppressive factors in cancer.
D000510:Alpha-Globulins; D000818:Animals; D000906:Antibodies; D000951:Antigens, Neoplasm; D001402:B-Lymphocytes / Q000276:immunology; D001667:Binding, Competitive; D002286:Carcinoma, Ehrlich Tumor / Q000276:immunology; D002465:Cell Movement; D005333:Fetus / Q000276:immunology; D006801:Humans; D007109:Immunity; D007156:Immunologic Memory; D007165:Immunosuppression Therapy; D007938:Leukemia / Q000276:immunology; D008213:Lymphocyte Activation; D008264:Macrophages / Q000276:immunology; D008970:Molecular Weight; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000276:immunology*; D009374:Neoplasms, Experimental / Q000276:immunology; D010587:Phagocytosis; D012313:RNA / Q000276:immunology; D013154:Spleen / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D000509:alpha-Fetoproteins
D000510:Alpha-Globulins; D000906:Antibodies; D000951:Antigens, Neoplasm; D000509:alpha-Fetoproteins; D012313:RNA